(EMAILWIRE.COM, January 23, 2019 ) Key driver for microfluidics market is the ‐great (or rising) demand in point-of-care (POC) and in-vitro diagnostics. Application of microfluidics in HIV testing at POCs is expected to cut cost, thereby increase the demand for the technology. Another challenge for growth of market is implementation of emerging microfluidics technology in existing applications. To overcome this challenge, companies are investing in research and development.
#Download PDF Papere of Microfluidics Market spread across 228 Pages, Profiling
17 Companies and Supported with 166 Tables and 51 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=136837 .
Microfluidics market is projected to reach US$ 27.91 billion by 2023 from estimated US$ 10.06 billion in 2018, at a CAGR of 22.6%. Quick returns on investment coupled with the fast results and improved portability of the medical equipment embedded with microfluidics technology are the factors expected to drive the market during the forecast period.
#Table of Content
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Allergy Diagnostics Market, By Product & Service
7 Allergy Diagnostics Market, By Test
8 Allergy Diagnostics Market, By Allergen
9 Allergy Diagnostics Market, By End User
10 Allergy Diagnostics Market, By Region
11 Competitive Landscape
12 Company Profiles
12 Appendix
Click Here for More Information Microfluidic Market Report
http://www.whatech.com/market-research/medical/545813-microfluidics-market-set-to-grow-at-22-6-to-2023-projected-to-reach-us-27-91-billion-examined-in-new-market-research-report .
The major players in the microfluidics market are Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm Microfluidics (US), and QIAGEN (Netherlands). Other key players include Dolomite Microfluidics (UK), GYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK), OPKO Health (US), Waters (US), thinXXS Microtechnology (Germany), Abaxis (US), bioMrieux (France), Abbott (US), Dolomite Microfluidics (UK), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), Micronit Microtechnologies (Netherlands), MicroLiquid (Spain), MiniFAB (Australia), uFluidix (Canada), Micralyne (US), and Fluigent (France).
Key Target Audience:
Microfluidics-based product manufacturers & distributors
Microfluidic component manufacturers
Pharmaceutical and diagnostic companies
Research institutes
Medical device companies
Life science companies
Healthcare institutions (hospitals, medical schools, and outpatient clinics)
Government associations
Market research and consulting firms
Venture capitalists and investors
#Discount Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) – Global Forecast to 2023 report at http://www.rnrmarketresearch.com/contacts/discount?rname=136837 .
The report analyzes the microfluidics market and aims at estimating the market size and future growth potential of this market based on various segments such as application, component, material, and region. The report includes revenue analysis for various application of microfluidics equipment and components across the globe and a competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, SWOT analysis, and key market strategies.
Snehal
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
